Keywords
Citation
(2001), "Wolters Kluwer acquires SilverPlatter", Interlending & Document Supply, Vol. 29 No. 3. https://doi.org/10.1108/ilds.2001.12229cab.022
Publisher
:Emerald Group Publishing Limited
Copyright © 2001, MCB UP Limited
Wolters Kluwer acquires SilverPlatter
Wolters Kluwer acquires SilverPlatter
Keywords: Mergers and acquisitions, Publishing industry, Software
Wolters Kluwer has announced the acquisition of SilverPlatter Information, a provider of medical and scientific databases and related software. The company will be combined with Ovid Technologies in a manner which takes advantage of the complementary strengths of both organisations. The combination of SilverPlatter and Ovid Technologies will be a first class provider of research tools for medical and scientific researchers. The acquisition is in line with Wolters Kluwer's strategy to expand its electronic offering in the medical and scientific fields and integrate content with software and services. The acquisition of SilverPlatter, when announced, was subject to regulatory clearance.
SilverPlatter provides search and retrieval technology to medical, academic, corporate and educational researchers world-wide with access to more than 250 electronic reference databases. Its "SilverLinker" product offers more than 2.5 million links to over 6,500 journals and 2 million articles. The services of SilverPlatter are offered through the Internet, Intranet and local CD-ROM solutions.
Wolters Kluwer's main objective with the acquisition and integration of SilverPlatter is to create a comprehensive channel for medical and scientific information. The acquisition of SilverPlatter will more than double the size of Wolters Kluwer's presence in the rapidly growing market for electronic, medical and scientific information. The activities of SilverPlatter and Ovid are complementary in many ways: SilverPlatter has strong sales in the scientific market, while Ovid has its traditional strength in the medical market. SilverPlatter has developed leading market positions in Europe and emerging markets, whereas Ovid is strongest in the USA.
For more information, contact Annie Hull-Bom. Email: ir@wolterskluwer.com
Source: Press release